A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 6, Pages e20209
Publisher
Public Library of Science (PLoS)
Online
2011-06-02
DOI
10.1371/journal.pone.0020209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preventing mucosal HIV transmission with topical microbicides: Challenges and opportunities
- (2010) Florian Hladik et al. ANTIVIRAL RESEARCH
- Treatment of HIV infection with the CCR5 antagonist maraviroc
- (2010) Wiete Kromdijk et al. EXPERT OPINION ON PHARMACOTHERAPY
- Protection of Rhesus Macaques from Vaginal Infection by Vaginally Delivered Maraviroc, an Inhibitor of HIV‐1 Entry via the CCR5 Co‐Receptor
- (2010) Ronald S. Veazey et al. JOURNAL OF INFECTIOUS DISEASES
- Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice
- (2010) Paul W. Denton et al. PLoS One
- Oral Pre-Exposure Prophylaxis by Anti-Retrovirals Raltegravir and Maraviroc Protects against HIV-1 Vaginal Transmission in a Humanized Mouse Model
- (2010) C. Preston Neff et al. PLoS One
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
- (2010) Q. Abdool Karim et al. SCIENCE
- The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
- (2009) Samuel Broder ANTIVIRAL RESEARCH
- Humanized Mice for Modeling Human Infectious Disease: Challenges, Progress, and Outlook
- (2009) Nicolas Legrand et al. Cell Host & Microbe
- Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2-/- c-/- Mouse
- (2009) S. K. Choudhary et al. JOURNAL OF VIROLOGY
- Pharmaceutical development of microbicide drug products
- (2009) David R. Friend PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- The utilization of humanized mouse models for the study of human retroviral infections
- (2009) Rachel Van Duyne et al. Retrovirology
- Humanized Rag2−/−γc−/− (RAG-hu) mice can sustain long-term chronic HIV-1 infection lasting more than a year
- (2009) Bradford K. Berges et al. VIROLOGY
- Reviews Of Anti‐infective Agents: Maraviroc: The First of a New Class of Antiretroviral Agents
- (2008) Rodger D. MacArthur et al. CLINICAL INFECTIOUS DISEASES
- Vaginal microbicides and the prevention of HIV transmission
- (2008) Blayne Cutler et al. LANCET INFECTIOUS DISEASES
- Whither or Wither Microbicides?
- (2008) R. M. Grant et al. SCIENCE
- Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2−/−γc−/− (RAG-hu) mice
- (2008) Bradford K. Berges et al. VIROLOGY
- Microbicide safety/efficacy studies in animals: macaques and small animal models
- (2008) Ronald S Veazey Current Opinion in HIV and AIDS
- Antiretroviral Pre-exposure Prophylaxis Prevents Vaginal Transmission of HIV-1 in Humanized BLT Mice
- (2008) Paul W Denton et al. PLOS MEDICINE
- Antiretroviral Drug–Based Microbicides to Prevent HIV-1 Sexual Transmission
- (2007) Per Johan Klasse et al. Annual Review of Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now